The expression of ANRIL was significantly up-regulatedin the CAD+ group (fold change=2.28, P=0.012) (Fig .1).This suggests that the expression of ANRIL is associatedwith atherosclerosis susceptibility in T2DM patients. The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.